Global Obstructive Airway Diseases Medicine Sales by Country

In 2023, Croatia leads with the highest per capita sales ($66.2), followed by Germany ($32.3) and Norway ($29.4). Significant growth was recorded in Germany (3.57%) and Australia (3.46%), while Italy and South Korea experienced declines of -0.83% and -0.65%, respectively.

Future Trends to Watch: The emerging trends indicate a potential surge in countries investing in advanced medical therapies and innovations. Watch for changes in regulatory frameworks, healthcare funding, and demographic shifts, which could significantly impact the markets, particularly in Europe and Asia.

Top countries in Obstructive Airway Diseases Medicine Sales by Country

# 8 Countries US Dollars Per Capita Last Year YoY 5-years CAGR
1 1 Croatia 66.2 2023 +0.3% +0.43% View data
2 2 Germany 32.3 2023 +1.89% +3.57% View data
3 3 Norway 29.4 2023 +2.8% +0.91% View data
4 4 Australia 22.4 2023 +1.36% +3.46% View data
5 5 Italy 18.8 2023 +3.3% -0.83% View data
6 6 Slovenia 12.6 2023 +4.13% +3.13% View data
7 7 Latvia 6.1 2023 +1.67% +1.01% View data
8 8 South Korea 6 2023 0% -0.65% View data

Top Countries about Ear, Nose, And Throat Medicine